Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

• Status: Completed
• Trial end date: 2022-01-05
• Target enrollment: 0
• Participant gender: Male

Summary

The aim of this current study is to estimate serum level of YKL-40, serum total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3 months.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Aswan University
• Treatments: Tadalafil

Criteria

Inclusion Criteria:

• Diabetic patients with ED.

Exclusion Criteria:

• Patients with history of pelvic trauma.

• Patients with major pelvic surgical intervention.

• Patients with hypogonadism and hyperprolactinemia.

• Patients with chronic liver disease.

• Patients with cardio vascular system diseases.

• History of chronic intake of central nervous system, anti androgen drugs or other drugs as Tramadol.

• Smokers patients.

• Patients with non-vasculogenic Erectile dysfunction.